Anatoly Dritschilo - Dec 29, 2022 Form 4 Insider Report for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Role
CEO and Chairman, Director, 10%+ Owner
Signature
/s/ Anatoly Dritschilo
Stock symbol
SHPH
Transactions as of
Dec 29, 2022
Transactions value $
-$13,437
Form type
4
Date filed
1/3/2023, 05:20 AM
Previous filing
Sep 8, 2022
Next filing
Aug 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SHPH COMMON STOCK Sale -$13.4K -8.37K -0.77% $1.61 1.09M Dec 29, 2022 Direct F1, F2
holding SHPH COMMON STOCK 3.2M Dec 29, 2022 By spouse F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 22,748 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.
F2 Consists of 1,085,200 shares of common stock held directly by the Reporting Person.
F3 Consists of 3,204,407 shares of common stock held by the Reporting Person's spouse, over which the Reporting Person disclaims any beneficial ownership or control. The inclusion in this report of the 3,204,407 shares held by the Reporting Person's spouse shall in no way be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.